Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0602
D

Failure to Account for and Safeguard Resident Medication

Naples, Florida Survey Completed on 05-30-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to properly identify, investigate, and prevent the misappropriation of a resident's physician-prescribed medication. A review of records showed that a resident had an active order for Fioricet, a medication for migraine headaches, with 30 capsules delivered by the pharmacy. However, only 11 capsules were documented as administered over a ten-day period, leaving 19 capsules unaccounted for. The resident reported not receiving the medication for a period of time, experiencing significant pain as a result. The facility's grievance log and investigation documentation did not accurately reflect the medication delivery and administration timeline, and the missing doses were not accounted for in the records. Further review and interviews revealed that the medication was not consistently stored in a double-locked drawer, and pharmacy audits did not include spot checks for this medication. The pharmacy consultant confirmed that Fioricet is not a controlled substance and therefore was not required to be double-locked, but acknowledged that one of its ingredients is a barbiturate. The facility's corporate DON suggested that the issue may have been due to documentation errors, as nurses failed to sign out the medication approximately 20 times. No additional packages of the medication were found, and the missing doses remained unaccounted for.

An unhandled error has occurred. Reload 🗙